TECHNOLOGY · 2014 · 27 citations · 28 references
Life SciencesImmunologyBiosensorsClinical ImmunologyImmunotechnologyAntibody-antigen RecognitionEnzyme-linked Immunosorbent AssayMultiplexed BiosensingAssayDiagnostic BiomarkersEarly Disease DetectionHomogeneous AssaysImmunoassaysMultiplex Diagnostic AssaysMultiplexed AssaysProtein Biomarkers
Quantitative measurement of protein biomarkers is critical for biomarker validation and early disease detection. Current multiplex immunoassays are time consuming costly and can suffer from low accuracy. For example, multiplex ELISAs require multiple, tedious, washing and blocking steps. Moreover, they suffer from nonspecific antibody cross-reactions, leading to high background and false-positive signals. Here, we show that co-localizing antibody-bead pairs in an aqueous two-phase system (ATPS) enables multiplexing of sensitive, no-wash, homogeneous assays, while preventing nonspecific antibody cross-reactions. Our cross-reaction-free, multiplex assay can simultaneously detect picomolar concentrations of four protein biomarkers ((C-X-C motif) ligand 10 (CXCL10), CXCL9, interleukin (IL)-8 and IL-6) in cell supernatants using a single assay well. The potential clinical utility of the assay is demonstrated by detecting diagnostic biomarkers (CXCL10 and CXCL9) in plasma from 88 patients at the onset of the clinical symptoms of chronic graft-versus-host disease (GVHD).
28
Limit of blank, limit of detection and limit of quantitation.
David Armbruster, Terry Pry · PubMed · 2008 · 2.1K citations · Full text
A biomarker panel for acute graft-versus-host disease
Sophie Paczesny, Oleg I. Krijanovski, Thomas Braun et al. · Blood · 2008 · 401 citations · Full text
The Use of AlphaScreen Technology in HTS: Current Status
Richard M. Eglen, Terry Reisine, Philippe Roby et al. · Current Chemical Genomics · 2008 · 257 citations · Full text